Megan Price, MSN, APRN, FNP-C, Virginia Seery, CRNP, MSN, Laura Wood, RN, MSN, OCN
The practice of using combinations of drugs in chemotherapy is not new and continues to evolve to include immune checkpoint inhibitors. Drug combinations can be more effective than single-agent therapy and may also reduce the risk of developing resistance. However, combining multiple drugs may increase the risk of drug interactions. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss how they have a conversation with their patients about the benefits and risks of using drug combinations in anticancer therapy.
Please submit your manuscripts using the form below. Papers submitted to our journal usually have a first decision within 4-6 weeks. If you have any questions, please contact the Editorial Director at email@example.com.